Latest News & Features
Americas
Gilead has obtained exclusive worldwide rights to market a long-acting injectable HIV product based on Durect Corporation’s Saber technology. 24 July 2019
Americas
The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica. 24 July 2019
Big Pharma
The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency. 23 July 2019
Americas
Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley. 23 July 2019
Americas
Ireland-headquartered Endo Pharmaceuticals agreed to pay $2.3 million to 18 states late last week, settling allegations that the drugmaker paid a competitor to keep a generic version of pain relief drug Lidoderm off the market. 22 July 2019
Americas
Eversheds Sutherland has continued its expansion in the US, with the opening of a San Diego office and the addition of three IP litigators. 22 July 2019
Americas
The US Patent and Trademark Office has granted Mammoth Biosciences applications for two patents covering what the company claims are “first-of-their-kind” CRISPR diagnostic techniques. 19 July 2019
Asia
Hong Kong customs authorities have carried out a series of raids resulting in the seizure of counterfeit vaccines worth over HKD $1 million, some containing poison. 18 July 2019
Big Pharma
Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year. 18 July 2019
Americas
Massachusetts-based medical laser company Candela and Israeli medical devices manufacturer Lumenis have settled all outstanding patent litigation between the two parties. 18 July 2019